The CLARITY Act, passed by the U.S. House and pending Senate approval, aims to classify Bitcoin and Ethereum as digital commodities under CFTC oversight, potentially resolving years of regulatory uncertainty caused by the Howey test. Senate disputes over stablecoin yield limits and DeFi liability continue to delay the bill, reflecting broader tensions between traditional finance and crypto markets. Despite recent Bitcoin price rebounds, weak U.S. spot demand and regulatory uncertainty have kept institutional investors cautious. If passed, the Act could improve custody rules and remove barriers for institutional spot market participation, marking a significant shift toward more stable, institutional-driven Bitcoin demand.
Candel Therapeutics is shifting from a risky clinical-stage biotech to a late-stage oncology company, driven by its lead asset CAN-2409 which showed positive Phase III results in localized prostate cancer. Additional promising data in non-small cell ...
The paper company reported Q1 EBITDA slightly above expectations despite weather disruptions, supported by lower industry supply, declining imports, price increases, and better utilization rates. Conservative recovery assumptions estimate an adjusted...
MediaAlpha reported Q1 revenue of $310 million and adjusted EBITDA of $31.4 million, surpassing guidance due to increased participation from insurance carriers and strong growth in property and casualty (P&C) insurance. The company now generates 93% ...
French President Emmanuel Macron and Indian Prime Minister Narendra Modi are actively courting major tech CEOs to secure investments in AI data centers, cloud infrastructure, and semiconductor development. Macron successfully persuaded SoftBank to in...
XRP rose over 5% as traders focused on Ripple's expanding cross-border payments network and improving regulatory outlook in the U.S. Despite some resistance near $1.20, XRP's short-term momentum is positive with growing adoption expectations for the ...
